Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy


Journal article


Conrad-Amadeus Voltin, Philipp Gödel, Laura Beckmann, Jan-Michel Heger, Carsten Kobe, Nadine Kutsch, Peter Borchmann, Markus Dietlein, Ken Herrmann, Matthias Stelljes, Kambiz Rahbar, Georg Lenz, H Christian Reinhardt, Marcel Teichert, Richard Noppeney, Jörn C Albring, Robert Seifert, Bastian von Tresckow, Sarah Flossdorf, Christine Hanoun
Hemasphere, 2023


Cite

Cite

APA   Click to copy
Voltin, C.-A., Gödel, P., Beckmann, L., Heger, J.-M., Kobe, C., Kutsch, N., … Hanoun, C. (2023). Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy. Hemasphere. https://doi.org/10.1097/HS9.0000000000000817


Chicago/Turabian   Click to copy
Voltin, Conrad-Amadeus, Philipp Gödel, Laura Beckmann, Jan-Michel Heger, Carsten Kobe, Nadine Kutsch, Peter Borchmann, et al. “Outcome Prediction in Patients With Large B-Cell Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.” Hemasphere (2023).


MLA   Click to copy
Voltin, Conrad-Amadeus, et al. “Outcome Prediction in Patients With Large B-Cell Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.” Hemasphere, 2023, doi:10.1097/HS9.0000000000000817.


BibTeX   Click to copy

@article{conrad-amadeus2023a,
  title = {Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy},
  year = {2023},
  journal = {Hemasphere},
  doi = {10.1097/HS9.0000000000000817},
  author = {Voltin, Conrad-Amadeus and Gödel, Philipp and Beckmann, Laura and Heger, Jan-Michel and Kobe, Carsten and Kutsch, Nadine and Borchmann, Peter and Dietlein, Markus and Herrmann, Ken and Stelljes, Matthias and Rahbar, Kambiz and Lenz, Georg and Reinhardt, H Christian and Teichert, Marcel and Noppeney, Richard and Albring, Jörn C and Seifert, Robert and von Tresckow, Bastian and Flossdorf, Sarah and Hanoun, Christine}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in